Reporter October 2023

October 18, 2023

Department of Radiology to host third annual Diversity, Equity and Inclusion Week

The Department of Radiology and Radiological Sciences at Vanderbilt is set to host its third annual Diversity, Equity, and Inclusion Week Oct. 23-27

By Jackson Hicks
October 18, 2023

VUMC’s Wei Kelly Wu, Siru Liu named 2023 Stat Wunderkinds

Vanderbilt’s Wei Kelly Wu, MD, and Siru Liu, PhD, have been named 2023 Stat Wunderkinds.

By Paul Govern
October 17, 2023

Powers announces plan to step down from key diabetes leadership roles

Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.

By Jill Clendening
The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee, BS; Simone Calò, PhD; and Pietro Valdastri, PhD. (hoto by Susan Urmy)
October 17, 2023

VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.

By Jill Clendening
October 17, 2023

Vanderbilt’s Ellen Clayton and Allison McCoy elected fellows of ACMI

Vanderbilt’s Ellen Clayton, MD, JD, and Allison McCoy, PhD, have been elected to the American College of Medical Informatics (ACMI) class of 2023.

By Mia Garchitorena-Scancarelli
October 17, 2023

AI predicts blood clot risk in hospitalized children: VUMC study

An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.

By Bill Snyder
October 17, 2023

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
By Tom Wilemon
October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.
By Jill Clendening
October 17, 2023

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.
By Bill Snyder
October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.
By Craig Boerner
October 12, 2023

Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4

A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
By Tom Wilemon
1 2 3 4